Learn about reducing the risk of blood clots using CRESTOR 20mg in this report from Insider Medicine.
Read the full transcript »
Dr. Susan Sharma: This is Insidermedicine in 60. From Orlando - CRESTOR 20 mg can reduce the risk of blood clots, according to an analysis from the JUPITER study. Patients were selected based on high sensitivity C-reactive protein and low-to-normal cholesterol levels. The study found that CRESTOR 20 mg, compared with placebo, reduced risk of venous thromboembolism by 43%. CRESTOR is a statin medication used to lower LDL cholesterol and prevent plaque buildup in the arteries. From Boston - According to a study published in the Journal Pediatrics, infants who gain weight suddenly in the first six months of life are more likely to obese by age three. The study examined nearly 560 mother-child pairs, measuring changes in the child's weight and length over three years. Rapid weight gain was found to be a more significant factor than the weight of the parents, the weight of the mother during pregnancy, and the weight of the child at birth. Finally, from Atlanta - Exercise is a necessary measure for preventing heart disease, according to a study presented at the American College of Sports Medicine Health & Fitness Summit & Exposition. Modifiable risk factors for heart disease include: hypertension, diabetes, smoking, high cholesterol levels, and an inactive lifestyle. Exercise affects one's inactivity and consequently improves the other modifiable risk factors. For Insidermedicine in 60, I am Dr. Susan Sharma.